期刊文献+

核因子kappa B与卵巢上皮癌血管生成及复发的关系研究 被引量:1

the Relationship with Angiogenesis and Relapse of Nuclear Factor-kappa B in Ovarian Epithelial Carcinoma
下载PDF
导出
摘要 目的研究核因子kappa B(nuclear factor-kappa B,NF-κB)与卵巢上皮癌(ovarian epithelial carcinoma,OEC)血管生成及复发的关系。方法应用免疫组化方法检测36例OEC,15例卵巢良性肿瘤和15例正常卵巢组织微血管密度(Microvessel density,MVD),碱性成纤维生长因子(basic fibroblast growth factor,bFGF)和NF-κB的表达。同时研究NF-κB和bFGF,MVD关系及OEC患者1、3、5年复发率。结果 NF-κB在OEC中的阳性表达率显著高于良性肿瘤和正常卵巢组织。在NF-κB阳性表达组,MVD和1、3、5年复发率显著高于NF-κB阴性组。NF-κB表达与MVD和bFGF表达正相关。结论 NF-κB可能通过上调bFGF的表达促进血管生成引起OEC的转移和复发。 Objective To investigate the relationship with angiogenesis and relapse of nuclear factor-kappa B(NF-κB)in ovarian epithelial carcinoma(OEC).Methods Microvessel density(MVD),expression of basic fibroblast growth factor(bFGF) and NF-κB were investigated in 36 cases of OEC,15 cases of ovarian benign tumor and 15 cases of normal ovarian specimens by immunohistochemical staining.The relationship between the NF-κB and bFGF,MVD and relapse rate of I,3 and 5 years of OEC patients were also studied.Results Positive expression rate of NF-κB in OEC was significantly higher than that of benign tumor and normal ovarian tissue.In NF-κB positive expression group,MVD and relapse rate of 1,3 and 5 years were significantly higher than those in NF-κB negative group.There were positive relationship between the expression of NF-κB and MVD.Conclusion NF-κB might promote angiogenesis through up-regulating bFGF expression and cause cancer metastasis and relapse in OEC.
出处 《中国医药指南》 2013年第9期428-429,共2页 Guide of China Medicine
关键词 NF-ΚB 血管生成 复发 OEC NF-κB Angiogenesis Relapse OEC
  • 相关文献

参考文献5

  • 1Pirtea L,Raica M,Cimpean AM.Endothelial cell activation and pro-liferation in ovarian tumors:Two distinct steps as potential markersfor antiangiogenic therapy response[J].Mol Med Report,2012,5(5):1181-1184.
  • 2Jain RK.Normalization of tumor vasculature:an emerging conceptin antiangiogenic therapy[J].Science,2005,307(5706):58–62.
  • 3Li T,Jiang S.Effect of bFGF on invasion of ovarian cancer cells thr-ough the regulation of Ets-1 and urokinase-type plasminogen acti-vator[J].Pharm Biol,2010,48(2):161-165.
  • 4Lou H,Kaplowitz N.Glutathione depletion down-regulates tumornecrosis factor alpha-induced NF-kappaB activity via IkappaBkinase-dependent and-independent mechanisms[J].J Biol Chem,2007,282(40):29470–29481.
  • 5杨丽华,王凯峰,周轶萍,李玛琳.核因子κB在人卵巢癌血管生成中的作用及机制[J].癌症,2004,23(5):531-534. 被引量:8

二级参考文献10

  • 1Paley PJ.Angiogenesis in ovarian cancer:molecular pathology and therapeutic strategies [J].Curr Oncol Rep,2002,4(2):165-174.
  • 2Brown MR,Blanchette JO,Kohn EC.Angiogenesis in ovarian cancer [J].Baillieres Best Pract Res Clin Obstet Gynaecol,2000,14(6):901-918.
  • 3Yoshida S,Ono M,Shono T,et al.Involvement of interleukin-8,vascular endothelial growth factor.And basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis [J].Mol Cell Biol,1997,(17):4015-4023.
  • 4Brand KS,Page G,Rogler A,et al.Activated transcription factor nuclear factor-kappa B is present in the atheroscerotic lesion [J].J Clin Invest,1996,97:1715-1722.
  • 5Stoltz RA,Abraham NG,Schwartzman ML.The role of NF-kappa B in the angiogenic response of coronary microvessel endothelial cells [J].Proc Natl Sci USA,1996,93:2832-2837.
  • 6Ribatti D,Nico B,Vacca A,et al.Chorioallantoic membrane capillary bed:a useful target for studying angiogenesis and anti-angiogenesis in vivo [J].Anat Rec,2001,264(4):317-324.
  • 7Raziuddin A,Court D,Sarkar FH,et al.A c-erbB-2 promoter-specific nuclear matrix protein from human breast tumor tissues mediates NF-kappa DNA binding activity [J].J Biol Chem,1997,272:15715-15720.
  • 8Shattuck BRL,Richmond A.Enhanced degradation of I-kappa alpha contributes to endogenous activation of NF-kappa in Hs294T melanoma cell [J].Cancer Res,1997,57:3032-3039.
  • 9Siebenlist U,Franzoso G,Borozon K.Structure,regulation and function of NF-kappa B [J].Annu Rev Cell Biol,1994,10:405-455.
  • 10Sharma HW,Higgins SK,Perez R,et al.A DNA motif present in alpha V integrin promoter exhibits to dual binding preference to distinct transcrirption factors [J].Anticancer Res.1995.15(5B):1857-1867.

共引文献7

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部